Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue
Total revenue	$ 795,078	$ 1,703,496	$ 1,799,310	$ 3,458,650
Operating Expenses and Costs
Practice salaries and benefits	513,891	898,992	1,097,047	1,862,649
Other practice operating expenses	389,222	646,216	871,805	1,270,463
Cost of product revenue	24,723	34,397	55,302	66,457
Selling, general and administrative expenses	861,469	833,689	1,860,912	1,937,437
Depreciation and amortization	85,262	88,293	171,771	176,370
Total Operating Expenses and Costs	1,874,567	2,501,587	4,056,837	5,313,376
Loss from operations	(1,079,489)	(798,091)	(2,257,527)	(1,854,726)
Other Income (Expenses)
Loss on extinguishment of debt	(73,567)	(44,169)	(170,227)	(88,932)
Change in fair value of debt	27,900		27,900
Amortization of original issue discounts on notes payable	(371,356)	(128,689)	(479,621)	(192,049)
Gain from realization of contingent sale consideration receivable		15,000		15,000
Change in fair value of contingent acquisition consideration	635	6,070	711	4,364
Interest expense and other	(44,559)	(39,124)	(49,390)	(50,505)
Total other income (expenses)	(460,947)	(190,912)	(670,627)	(312,122)
Loss from continuing operations before provision for income taxes	(1,540,436)	(989,003)	(2,928,154)	(2,166,848)
Provision for income taxes
Loss from continuing operations	(1,540,436)	(989,003)	(2,928,154)	(2,166,848)
Discontinued operations (Note 4)
Loss from operations of discontinued operations		(14,452)		(58,741)
Gain from disposal of discontinued operations				2,674,069
Gain (loss) on discontinued operations		(14,452)		2,615,328
Net income (loss)	$ (1,540,436)	$ (1,003,455)	$ (2,928,154)	$ 448,480
Loss per share from continuing operations, basic and diluted:
Basic (in Dollars per share)	$ (0.01)	$ 0	$ (0.01)	$ (0.01)
Fully diluted (in Dollars per share)	(0.01)	0	(0.01)	(0.01)
Gain (loss) on discontinued operations, basic and diluted:
Basic (in Dollars per share)	0	0	0	0.01
Fully diluted (in Dollars per share)	0	0	0	0.01
Net loss per share, basic and diluted:
Basic (in Dollars per share)	(0.01)	0	(0.01)	0
Fully diluted (in Dollars per share)	$ (0.01)	$ 0	$ (0.01)	$ 0
Weighted average number of common shares:
Basic (in Shares)	281,788,578	259,817,248	281,136,423	258,481,657
Fully diluted (in Shares)	281,788,578	259,817,248	281,136,423	258,481,657
Patient service revenue, net
Revenue
Total revenue	$ 763,163	$ 1,630,334	$ 1,726,784	$ 3,330,615
Subscription revenue
Revenue
Total revenue	8,166	19,177	15,794	35,476
Product revenue
Revenue
Total revenue	$ 23,749	$ 53,985	$ 56,732	$ 92,559